Abstract
Over-expression of P-glycoprotein (Pgp), a protein responsible for multidrug resistance (MDR), is responsible for general resistance to anti-epileptic drugs (AEDs). We explored the potential use of gene therapy with adenoviral-delivered RNA interference against mdr1b as a method to sensitize refractory epilepsy to AEDs. We constructed replication-deficient recombinant adenovirus Adeno-mdr1b1 carrying short hairpin RNA (shRNA) targeting against mdr1b, and successfully infected the established Sprague–Dawley rat astrocyte model of Coriaria Lactone-induced Pgp over-expression. The expression levels of mdr1b and Pgp and the Rhodamine123 efflux ratio in trial groups were significantly lower than that of blank control (P < 0.05) during the first 7 days post-infection, with the most inhibition at 48 h. The results suggest that knockdown of MDR using adenovirus not only avoided the toxicity and low rate of plasmid nucleofection, but also overcame its poor efficiency of mdr1b silencing. More importantly, this study may pave the way for a promising approach to remedy refractory epilepsy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abbott NJ (2002) Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 200:629–638
Aleman C, Annereau JP, Liang XJ, Cardarelli CO, Taylor B, Yin JJ (2003) P- glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential. Cancer Res 63:3084–3091
Aronica E, Gorter JA, Ramkema M, Redeker S, Ozbas-Gerceker F, van Vliet EA (2004) Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia 45:441–451
Barkats M, Bilang-Bleuel A, Buc-Caron M, Hughes S, McQuillan PJ, Castel-Barthe MN, Corti O, Finiels F, Horellou P, Revah F, Sabate O, Mallet J. (1998) Adenovirus in the brain: recent advances of gene therapy for neurodegenerative disease. Prog. Neurobiol 55:333–341
Chen MK, Strande LF, Beierle EA, Kain MS, Geldziler BD, Doolin EJ (1999) Fas-mediated induction of hepatocyte apoptosis in a neuroblastoma and hepatocyte coculture model. J Surg Res 84:82–87
Cole R, de Vellis J (2001) Preparation of astrocyte, oligodendrocytes, and microglia cultures from primary rat cerebral cultures. In Fedoroff S, Richardson A (eds) Protocols for neural cell culture, vol 3. Humana Press Inc., pp 117–128
Davidson BL, Hilfinger JM, Beer SJ (1997) Extended release of adenovirus from polymer microspheres: potential use in gene therapy for brain tumors. Adv Drug Deliv Rev 27:59–66
Demeule M, Labelle M, Regina A, Berthelet F, Beliveau R (2001) Isolation of endothelial cells from brain, lung, and kidney: expression of the multidrug resistance P-glycoprotein isoforms. Biochem Biophys Res Commun 281:827–834
Elbashir SM, Harborth J, Weber K, Tuschl T (2002) Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26:199–213
Etienne-Manneville S, Manneville JB, Nicholls S, Ferenczi MA, Hall A (2005) Cdc42 and Par6-PKC regulate the spatially localized association of Dlg1 and APC to control cell polarization. J Cell Biol 170:895–901
Hannon GJ (2002) RNA interference. Nature 418:244–251
Hommel RM, Sears D, Georgescu (2003) Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med 9:1539–1544
Hua J, Mutch DG, Herzog TJ (2005) Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line. Gynecol Oncol 98:1–38
Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta 455:152–156
Kudo Y, Niwa H, Tanaka A (1984) Actions of picrotoxin and related compound on the frog spinal cord: the role of a hydroxylgroup at the 6-position in antagonizing the actions of amino acids and presynaptic inhibition. Br J Pharmacol 81:373–380
Lee G, Dallas S, Hong M (2001) Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacol Rev 53:569–596
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–428
Loscher W, Potschka H (2002) Role of multidrug transporters in pharmacoresistance to anti-epileptic drugs. J Pharmacol Exp Ther 301:7–14
Lu Y, Yan Y, Wang XF (2004) Antiepileptic drug-induced multidrug resistance P-glycoprotein overexpression in astrocytes cultured from rat brains. Chin Med J 117:1682–1686
Mercier C, Decleves X, Masseguin C, Fragner P, Tardy M, Roux F (2003) P-glycoprotein (ABCB1) but not multidrug resistance-associated protein 1 (ABCC1) is induced by doxorubicin in primary cultures of rat astrocytes. J Neurochem 87:820–830
Morrow CS, Cowan KH (1988) Mechanisms and clinical significance of multidrug resistance. Oncology 2:55–63
Regina A, Koman A, Piciotti M (1998) Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem 71:705–715
Shi Z, Liang YJ, Chen ZS, Wang XW, Wang XH, Ding Y (2006) Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo. Cancer Biol Ther 5:39–47
Sisodiya SM, Lin WR, Harding BN, Squier MV, Thom M (2002) Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125:22–31
Thallah-Shaykh HM, Kafrouni AI, Zhao LJ (2000) Demyelination but no cognitive, motor or behavioral deficits after adenovirus-mediated gene transfer into the brain. Gene Ther 7:2094–2098
Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J (2005) An astrocytic basis of epilepsy. Nat Med 11:973–981
Tishler DM, Weinberg KI, Hinton DR, Barbaro N, Annett GM, Raffel C (1995) MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 36:1–6
van Vliet EA, van Schaik R, Edelbroek PM, Redeker S, Aronica E, Wadman WJ, Marchi N, Vezzani A, Gorter JA (2006) Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia 47:672–680
Wang Y, Zhou D, Wang B, Li H, Chai H, Zhou Q (2003) A kingdling model of pharma-coresistant temporal lobe epilepsy in sprague-dawley rats induced by coriaria lactone and its possible mechanism. Epilepsia 44:475–488
Wood M.J.A, Charlton H.M, Kajikawa, K. Byrnes (1996) Immune responses to adenovirus vectors in the nervous system. Trends Neurosci 19:497–501
Wu BY, Liu RY, So KL, Yu AC (2000) Multi-lipofection efficiently transfected genes into astrocytes in primary culture. J Neurosci Methods 102:133–141
Yoshinari K, Miyagishi M, Taira K (2004) Effects on RNAi of the tight structure, sequence and position of the targeted region. Nucleic Acids Res 32:691–699
Zhang L, Ong WY, Lee T (1999) Induction of P-glycoprotein expression in astrocytes following intracerebroventricular kainate injections. Exp Brain Res 126:509–516
Acknowledgments
This work was supported by the National Natural Science Foundation of China and West China Hospital (Nos. 30770749/C030307, 30370513/C030307).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, L., Tian, L., Yang, T. et al. Reversal of Mdr1b-dependent Multidrug Resistance in a Rat Astrocyte Model by Adenoviral-delivered Short Hairpin RNA. Cell Mol Neurobiol 28, 1057–1066 (2008). https://doi.org/10.1007/s10571-008-9283-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-008-9283-0